
Browsing restrictions can be lifted for a fee.
InnoCare Optoelectronics Corporation engages in the design, development, manufacture, and sale of X-ray flat panel detectors and sensors for healthcare, veterinary, security, and industrial applications in Taiwan and internationally. It offers thin film transistors and scintillators, and other medical products, as well as accessories, including power and ethernet cables, charger sets, and batteries. The company was founded in 2019 and is headquartered in Tainan City, Taiwan. InnoCare Optoelectronics Corporation operates as a subsidiary of Innolux Corporation.
6861
睿生光電
9.09%
(0.09)
The most recent financial report for 睿生光電 (6861) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 6861's short-term business performance and financial health. For the latest updates on 6861's earnings releases, visit this page regularly.
According to historical valuation range analysis, 睿生光電 (6861)'s current price-to-earnings (P/E) ratio is 14.63, placing it in the Overvalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning optimistic. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.
According to the latest financial report, 睿生光電 (6861) reported an Operating Profit of 21.8M with an Operating Margin of 3.93% this period, representing a growth of 144.31% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
In the latest financial report, 睿生光電 (6861) announced revenue of 554.84M, with a Year-Over-Year growth rate of 14.7%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
At the end of the period, 睿生光電 (6861) held Total Cash and Cash Equivalents of 734.89M, accounting for 0.3 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
In the latest report, 睿生光電 (6861) achieved the “three margins increasing” benchmark, with a gross margin of 24.31%%, operating margin of 3.93%%, and net margin of 5.36%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 6861's profit trajectory and future growth potential.
According to the past four quarterly reports, 睿生光電 (6861)'s earnings per share (EPS) shows a declining trend, with the latest EPS at 0.72. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
睿生光電 (6861)'s Free Cash Flow (FCF) for the period is 26.19M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 153.21% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.